Dr.

Rachel Harding (University of Toronto, SGC-Toronto), in collaboration with Agora Open Science Trust and the Structural Genomics Consortium (SGC), is leading a project focused on accelerating the development of targeted therapeutic strategies for Kennedy's Disease, also known as Spinal Bulbar Muscular Atrophy (SBMA). Dr. Harding received a research grant from the KDA to fund this project. She will collaborate with SBMA researchers in Italy and the UK in project implementation. Find out more: https://www.thesgc.org/news/new-open-science-project-funded-accelerate-therapeutic-discovery-spinal-bulbar-muscular #KDA #Kennedysdisease #SBMA #research